Drug recall · February 12, 2014
Cefepime for Injection USP and Dextrose Injection USP recall
Why: Presence of Particulate Matter: The 1g Cefepime for Injection USP and Dextrose Injection USP lot has been found to contain visible organic particulate matter in a reserve sample unit.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Cefepime for Injection USP and Dextrose Injection USP, in Duplex Drug Delivery System, 1 g in 50 mL duplex container, For IV Use Only, Single Dose, Sterile/Non pyrogenic, Rx Only, B Braun Medical Inc., NDC 0264-3193-11
- Lots / codes
Lot H3A744, Exp 01/15
- Quantity
- 18,936 Containers
- Company
- B. Braun Medical Inc, Irvine, CA
- Distribution
- Nationwide
- Initiated
- October 15, 2013 · Voluntary: Firm initiated
- Classified
- January 31, 2014
- Reported
- February 12, 2014
- Ended
- December 4, 2014
- How notified
- Press Release
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Cefepime
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.